201 related articles for article (PubMed ID: 17681761)
1. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.
Hashimoto K; Fujita Y; Horio M; Kunitachi S; Iyo M; Ferraris D; Tsukamoto T
Biol Psychiatry; 2009 Jun; 65(12):1103-6. PubMed ID: 19217074
[TBL] [Abstract][Full Text] [Related]
3. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
4. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
[TBL] [Abstract][Full Text] [Related]
6. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.
Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M
Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine.
Matsuura A; Fujita Y; Iyo M; Hashimoto K
Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314
[TBL] [Abstract][Full Text] [Related]
9. Is endogenous D-serine in the rostral anterior cingulate cortex necessary for pain-related negative affect?
Ren WH; Guo JD; Cao H; Wang H; Wang PF; Sha H; Ji RR; Zhao ZQ; Zhang YQ
J Neurochem; 2006 Mar; 96(6):1636-47. PubMed ID: 16476080
[TBL] [Abstract][Full Text] [Related]
10. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
Labrie V; Clapcote SJ; Roder JC
Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
[TBL] [Abstract][Full Text] [Related]
11. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
13. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
14. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Boulay D; Pichat P; Dargazanli G; Estenne-Bouhtou G; Terranova JP; Rogacki N; Stemmelin J; Coste A; Lanneau C; Desvignes C; Cohen C; Alonso R; Vigé X; Biton B; Steinberg R; Sevrin M; Oury-Donat F; George P; Bergis O; Griebel G; Avenet P; Scatton B
Pharmacol Biochem Behav; 2008 Nov; 91(1):47-58. PubMed ID: 18621075
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.
Tanii Y; Nishikawa T; Hashimoto A; Takahashi K
J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.
Grauer SM; Pulito VL; Navarra RL; Kelly MP; Kelley C; Graf R; Langen B; Logue S; Brennan J; Jiang L; Charych E; Egerland U; Liu F; Marquis KL; Malamas M; Hage T; Comery TA; Brandon NJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):574-90. PubMed ID: 19661377
[TBL] [Abstract][Full Text] [Related]
19. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
Yang SY; Hong CJ; Huang YH; Tsai SJ
Neurosci Lett; 2010 Jan; 469(1):127-30. PubMed ID: 19944746
[TBL] [Abstract][Full Text] [Related]
20. Contribution of endogenous glycine and d-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures.
Katsuki H; Watanabe Y; Fujimoto S; Kume T; Akaike A
Life Sci; 2007 Aug; 81(9):740-9. PubMed ID: 17698151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
